Skip to Main Content
TRC_PL_NEW
Menu
    • Products▾
      • CriticalPoint
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • NatMed Advisor
      • NatMed Pro
      • NetCE All Access
      • NetCE All Access: Behaviorial Health
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber Insights
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter Sub Menu Toggle
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse Sub Menu Toggle
    • Subject
    • Featured Charts & Graphics
    • Gender-Related Care
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
    • Student Resources
    • Faculty & Preceptor Resources
    • Journal Club
    • All Charts & Graphics
  • Podcasts
  • Charts & Graphics Sub Menu Toggle
    • Featured Charts & Graphics
    • Antidepressants
    • Contraceptives
    • Diabetes Drugs
    • Do Not Crush List
    • First Time Generics
    • New Drugs
    • All Charts & Graphics >
  • CE/CME & Training Sub Menu Toggle
    • CE Organizer
    • Available Courses
    • My Completions
    • Live Webinars
  • Help Sub Menu Toggle
    • User Support
    • Contact Us

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

  1. Home
  2. Browse
  3. Hematology & Oncology
  4. Resources
  5. Guidelines

Guidelines

  • Anemia (53)
  • Blood Products (5)
  • Breast Cancer (65)
  • Cancer (22)
  • Cervical Cancer (18)
  • Chemotherapy (6)
  • Chemotherapy-Induced Adverse Effects (34)
  • Colon Cancer (22)
  • Drugs/Products That May Increase Cancer Risk (119)
  • Gastrointestinal Cancers (33)
  • Hemophilia (4)
  • Hemorrhage (7)
  • Leukemia (1)
  • Lung Cancer (98)
  • Lymphoma & Multiple Myeloma (1)
  • Ovarian Cancer (5)
  • Prostate Cancer (29)
  • Renal Cancer (1)
  • Resources (76)
    • Charts (11)
    • Drugs (6)
    • Guidelines (3)
    • Letters (5)
    • Natural Medicines / Supplements (22)
    • Patient Education (5)
    • PL Voices (34)
    • Quality Measures (13)
  • Sickle Cell Disease (5)
  • Skin Cancer (24)
1 - 3 of 3 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Guideline: Use of 5-alpha Reductase Inhibitors for Prostate Cancer Chemoprevention (2008) August 2011
Commentary: Possible Increased Risk of Aggressive Prostate Cancer with Finasteride and Dutasteride August 2011
Guideline: Prevention and Treatment of Mucositis (2007) November 2009
  • 1
  • About Us
  • Our Mission
  • Our Team
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.



© 2025 Therapeutic Research Center. All Rights Reserved